Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.12.2013 | short review | Ausgabe 4/2013

memo - Magazine of European Medical Oncology 4/2013

Targeting AML with anti-CD33 antibodies: historical walkthrough, clinical impact, future directions

Zeitschrift:
memo - Magazine of European Medical Oncology > Ausgabe 4/2013
Autoren:
MD Spyridon Dimitrios Chondropoulos, MD Annaliza Delastic, MD Alexandros Spyridonidis

Abstract

In the past years, new emerging targeted therapies against specific markers have revolutionized the field of treating malignancies. In this article, we discuss the first available agent that targets a specific molecule in acute myeloid leukemia, as well as the future possibilities that genetic research unveil.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 4/2013

memo - Magazine of European Medical Oncology 4/2013 Zur Ausgabe